Investment Analysts’ Downgrades for May 4th (ADMA, AG, AGL, CHKP, CURB, FNWB, IDA, IIIN, PNFP, SPSC)

Investment Analysts’ downgrades for Monday, May 4th:

ADMA Biologics (NASDAQ:ADMA) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

First Majestic Silver (NYSE:AG) (TSE:FR) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.

Agilon Health (NYSE:AGL) was downgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an underweight rating. The firm currently has $21.00 price target on the stock.

Check Point Software Technologies (NASDAQ:CHKP) was downgraded by analysts at Bank of America Corporation from a buy rating to a neutral rating. The firm currently has $120.00 price target on the stock.

Curbline Properties (NYSE:CURB) was downgraded by analysts at Wall Street Zen from a sell rating to a strong sell rating.

First Northwest Bancorp (NASDAQ:FNWB) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.

IDACORP (NYSE:IDA) was downgraded by analysts at Wall Street Zen from a sell rating to a strong sell rating.

Insteel Industries (NYSE:IIIN) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.

Pinnacle Financial Partners (NYSE:PNFP) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.

SPS Commerce (NASDAQ:SPSC) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

United Natural Foods (NYSE:UNFI) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

Receive News & Ratings for ADMA Biologics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADMA Biologics Inc and related companies with MarketBeat.com's FREE daily email newsletter.